Pharmaceutical Investing Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer
Pharmaceutical Investing MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations
Pharmaceutical Investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
